Skip to main content

Certara Completes Acquisition of Chemaxon

The combined organization offers life sciences companies predictive biosimulation and scientific informatics capabilities, improving certainty in decision-making from discovery through commercialization. RADNOR, Pa., Oct. 02, 2024 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced it has completed the acquisition of Chemaxon. Chemaxon develops leading scientific informatics software products used by the life sciences industry for in-silico research. Certara develops advanced modeling and biosimulation solutions used to predict the pharmacokinetic and pharmacodynamic properties of large and small molecules. “Combining Chemaxon’s expertise with Certara’s biosimulation capabilities provides life sciences companies with unique solutions to enhance productivity...

Continue reading

Colliers expands engineering offering in Canada

Acquisition enhances scale and capabilities in Ontario TORONTO and OTTAWA, Oct. 02, 2024 (GLOBE NEWSWIRE) — Global diversified professional services and investment management company, Colliers (NASDAQ, TSX: CIGI), announced today that its Canadian engineering platform, Englobe Corporation (“Englobe”), has acquired Goodkey, Weedmark & Associates Limited (“GWAL”), a leading building engineering consulting firm in Ontario. The addition will strengthen Englobe’s scale and service capabilities in Canada’s largest market. GWAL’s leadership team will become shareholders of Englobe under Colliers’ unique partnership model. The business will be fully integrated into Englobe’s operations and will rebrand as Colliers in the future. Terms of the transaction were not disclosed. Founded in 1956, GWAL’s 100 professionals provide mechanical...

Continue reading

Mitratech Solidifies Position in Enterprise Risk Software, Connecting AI-Enabled Third-Party Risk Management, Business Continuity Planning, & More

Both organic development and recent dual acquisitions bolster interconnected risk management, adding rapid, coordinated incident response and expanded TPRM capabilitiesBoth organic development and recent dual acquisitions bolster interconnected risk management, adding rapid, coordinated incident response and expanded TPRM capabilitiesAUSTIN, Texas, Oct. 02, 2024 (GLOBE NEWSWIRE) — Mitratech, a global compliance technology leader for legal, risk, and HR teams, is excited to announce the expansion of its leading enterprise risk management platform with several technology developments and the dual acquisition of two companies: Preparis, a premier continuity planning platform for incident management and emergency response, and Prevalent, a leader in unified third-party risk management (TPRM). The advancements...

Continue reading

Crescendo Acquires Customer Operations Innovator PartnerHero

Responds to demand for augmented-AI platform by rapidly expanding global operations on six continents SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) — Crescendo, creators of the first augmented-AI customer experience (CX) platform, today announced the acquisition of PartnerHero, a leader in CX innovation with customers such as Airtable, Khan Academy, sweetgreen, Tom’s Shoes, Udemy and more. Price and terms of the deal were not disclosed. The combined companies aim to disrupt an estimated half trillion dollar plus market opportunity. The acquisition is the largest ever in high technology by an early-stage company and the company today also announced that it had raised $50 million in venture funding over the past year. Crescendo assembled a seasoned leadership and proved out its innovative augmented-AI approach to customer experience...

Continue reading

Techmer PM Expands Portfolio with Acquisition of OptiColor Inc.

The acquisition will bolster Techmer PM’s capabilities in the concentrate and compounds market CLINTON, Tenn., Oct. 02, 2024 (GLOBE NEWSWIRE) — Techmer PM, LLC, a global leader in polymer materials design, announced today the successful acquisition of OptiColor, Inc., a full-service color compounder specializing in color concentrates and masterbatches for critical applications. This strategic acquisition and the combined technology of the two organizations will further solidify Techmer PM’s position as an innovation leader in colorants and additives for the plastics industry, ensuring a promising future for the company and its stakeholders. OptiColor, a company with a strong foothold in the color compounds market, was established in Huntington Beach, Calif., in 1995. OptiColor’s expertise lies in compounding custom concentrates,...

Continue reading

Better Choice Company to Provide Update on SRx Health Transaction at the 2024 Sidoti Virtual Conference on November 13th & 14th

SRx Health Revenue for the fiscal year ending September 30, 2024 is expected to increase over 20% year-over-year to over CAD$200 million SRx Health management expects similar revenue growth year-over-year for fiscal 2025 Acquisition of SRx Health remains on-track TAMPA, Fla., Oct. 02, 2024 (GLOBE NEWSWIRE) — Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced it will present at the Sidoti Virtual Conference on November 13-14, 2024. During the conference, management will provide an update on its ongoing acquisition of SRx Health. SRx Health Preliminary Revenue for FY2024 Ending September 30, 2024 and FY2025 Revenue Guidance:Fiscal Year 2024: SRx Health management expects revenue to increase over 20% year-over-year to over CAD$200 million. Fiscal Year 2025: SRx...

Continue reading

Commure Completes Merger with Augmedix

SAN FRANCISCO, Oct. 02, 2024 (GLOBE NEWSWIRE) — Commure, a healthcare technology company, announced today that it has completed the acquisition of Augmedix. Augmedix will now operate as a wholly-owned subsidiary of Commure. The merger was previously announced on July 19, 2024, and was approved by Augmedix stockholders at Augmedix’s special meeting of stockholders held on September 27, 2024. With the completion of the acquisition, Augmedix stockholders are entitled to $2.35 in cash for each share of Augmedix common stock they owned immediately prior to the closing. Augmedix’s stock has ceased trading and will be delisted from the Nasdaq Stock Market. “I started Augmedix to relieve clinicians from administrative burdens that take them away from what matters most: patient care,” said Ian Shakil, founder of Augmedix. “Joining...

Continue reading

Compass Diversified-Backed Altor Solutions Completes Acquisition of Lifoam Industries

WESTPORT, Conn., Oct. 02, 2024 (GLOBE NEWSWIRE) — Compass Diversified (NYSE: CODI) today announced that its subsidiary, Altor Solutions (“Altor”), a leading designer and manufacturer of custom protective and cold-chain packaging solutions for the industrial and life sciences markets, completed its previously announced acquisition of Lifoam Industries, LLC (“Lifoam”), pursuant to the agreement entered into on August 15, 2024. The acquisition was completed for an enterprise value of $137 million (excluding working capital and certain other adjustments). Founded in 1954, Lifoam is a leading manufacturer of temperature-controlled packaging products such as thermal shippers and refrigerant gel packs for the healthcare, commercial and retail industries. Lifoam is a carve-out of the material sciences company Jadex Inc. “The addition of...

Continue reading

PharmaCorp Completes Acquisition of a Pharmacy in Atlantic Canada

SASKATOON, Saskatchewan, Oct. 02, 2024 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that, further to its news release dated September 25, 2024, it has completed the acquisition of a 100% interest in a pharmacy business including land and buildings (the “Acquired Pharmacy”) located in Atlantic Canada (the “Acquisition”). The aggregate purchase price for the Acquired Pharmacy was $15,377,013, of which $15,177,013 was paid using cash on hand and $200,000 was paid by issuing common shares of PharmaCorp (“Common Shares”). The deemed price for the Common Shares was $0.6616 pursuant to the price adjustment mechanism included in the applicable share purchase agreement. The Acquired Pharmacy represents PharmaCorp’s third acquisition including the successful completion of its...

Continue reading

Form 8.3 – TRINITY EXPLORATION & PRODUCTION PLC

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: VELAY FINANCIAL SERVICES LTD(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. Not applicable(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree TRINITY EXPLORATION & PRODUCTION PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: Not applicable(e)   Date...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.